HIPAA Efficacy Side effect Normal GFR Patient- Centered care Potency Agonist drug Evidence- based practice Systematic review Pharmacologic classification Bioavailability Free! Duration of action Peak and Trough levels Synergistic effects First- Pass effect Always Event Sensory Perception Informatics Peak action Quality improvement Incompatible Half- life Antagonist drug National Patient Safety Goal Normal ALT The Joint Commission Quality assurance Pharmacokinetics Metabolism Therapeutic index RACE Onset of action Pharmacodynamics PICO Sensoristasis Caring Adverse effect Therapeutic effect Never Event Normal BUN Additive effects Therapeutic classification Loading dose Antagonistic effects HIPAA Efficacy Side effect Normal GFR Patient- Centered care Potency Agonist drug Evidence- based practice Systematic review Pharmacologic classification Bioavailability Free! Duration of action Peak and Trough levels Synergistic effects First- Pass effect Always Event Sensory Perception Informatics Peak action Quality improvement Incompatible Half- life Antagonist drug National Patient Safety Goal Normal ALT The Joint Commission Quality assurance Pharmacokinetics Metabolism Therapeutic index RACE Onset of action Pharmacodynamics PICO Sensoristasis Caring Adverse effect Therapeutic effect Never Event Normal BUN Additive effects Therapeutic classification Loading dose Antagonistic effects
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
HIPAA
Efficacy
Side effect
Normal GFR
Patient-Centered care
Potency
Agonist drug
Evidence-based practice
Systematic review
Pharmacologic classification
Bioavailability
Free!
Duration of action
Peak and Trough levels
Synergistic effects
First-Pass effect
Always Event
Sensory Perception
Informatics
Peak action
Quality improvement
Incompatible
Half-life
Antagonist drug
National Patient Safety Goal
Normal ALT
The Joint Commission
Quality assurance
Pharmacokinetics
Metabolism
Therapeutic index
RACE
Onset of action
Pharmacodynamics
PICO
Sensoristasis
Caring
Adverse effect
Therapeutic effect
Never Event
Normal BUN
Additive effects
Therapeutic classification
Loading dose
Antagonistic effects